IP Library Granted Patent US 8,367,888
Granted Patent B2
US 8,367,888 · App. 12/476,087 · Granted Feb 5, 2013

Mouse λ light chain locus

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,367,888
App. No.
12/476,087
Granted
Feb 5, 2013
Kind
B2
Abstract

The present invention provides in a first aspect a mouse in which the λ (lambda) light chain locus has been functionally silenced. In one embodiment, the mouse λ light chain locus was functional silenced by deletion of gene segments coding for the λ light chain locus. In a further aspect, a mouse containing functionally silenced λ and κ (kappa) L chain loci was produced. The invention is useful for the production of antibodies, for example heterologous antibodies, including heavy chain only antibodies.

Claims (37)

1. A knock-out mouse having its lambda light chain locus C2-C4-C3-C1 deleted using LoxP constructs as the targeting constructs and ubiquitous Cre-expresser mice, wherein the knock-out mouse is produced by a method comprising the steps of:

(a) introducing at least one C3-C1 targeting construct that comprises LoxP sequences to a mouse embryonic stem (ES) cell, thereby producing a mouse ES cell having silenced C1;

(b) introducing the mouse ES cell having silenced C1 to a mouse embryo in order to produce a mouse having silenced C1 by germline transmission;

(c) breeding the mouse having silenced C1 with a Cre-expresser mouse, which causes targeted deletion of C3-C1;

(d) obtaining a C3-C1 deleted mouse as a result of the breeding of (c);

(e) obtaining a mouse ES cell from the C3-C1 deleted mouse;

(f) introducing a C2-C4 targeting construct that comprises a LoxP sequence to the mouse ES cell from the C3-C1 deleted mouse, thereby producing a mouse ES cell having silenced C2;

(g) introducing the mouse ES cell having silenced C2 to a mouse embryo in order to produce a mouse having silenced C2 by germline transmission;

(h) breeding the mouse having silenced C2 with a Cre-expresser mouse, which causes targeted deletion of C2-C4; and

(i) obtaining a knock-out mouse having deleted lambda locus C2-C4-C3-C1 as a result of the breeding of (h).

2. The knock-out mouse according to claim 1 , wherein κ light chain locus is functionally silenced by targeted integration of a selectable marker gene in Cκ or targeted removal of Cκ or Jκ.

3. The knock-out mouse according to claim 1 , wherein the mouse heavy chain locus is functionally silenced by targeted integration of a selectable marker gene in the μ membrane exons or targeted deletion of JH gene segment.

4. The knock-out mouse according to claim 1 , wherein the knock-out mouse comprises one or more heavy and/or a light chain genes or loci from a human.

5. A method of producing a knock-out mouse, wherein lambda light chain locus is deleted through knock-out by targeted integration and gene deletion using LoxP constructs as the targeting constructs and ubiquitous Cre-expresser mice, wherein the method comprises the step of deleting C2-C4 loci and C3-C1 loci.

6. A method of making a knock-out mouse having its lambda light chain locus deleted, wherein the method comprises the steps of:

(a) introducing at least one C2-C4 targeting construct to a mouse embryonic stem (ES) cell, thereby producing an ES cell having silenced C2 region;

(b) introducing the ES cell having the silenced C2 region to a mouse embryo in order to produce a mouse having silenced C2 region by germline transmission;

(c) obtaining a C2 deleted mouse by breeding the mouse of step (b) with another mouse capable of causing deletion of the targeted C2-C4 region by germline transmission;

(d) obtaining ES cells from a progeny mouse of step (c);

(e) introducing a C3-C1 targeting construct to the ES cell of step (d), thereby producing an ES cell having silenced C1 region;

(f) introducing the ES cell of step e) having the silenced C1 region to a mouse embryo in order to produce a mouse having silenced C1 region by germline transmission; and

(g) obtaining a mouse having deleted lambda locus regions C2-C4-C3-C1 by breeding the mouse of step (f) with another mouse capable of causing deletion of the targeted C3-C1 region in germline transmission, wherein the lambda light chain locus is deleted by the use of LoxP constructs as the targeting constructs and by the use of a ubiquitous Cre-expresser mouse as the mouse capable of deleting a targeted region.

7. A knock-out mouse in which the lambda light chain locus is deleted through knock-out by targeted integration and gene deletion, wherein the knock-out of the lambda light chain locus is carried out by a method comprising the steps of:

(a) introducing at least one C2-C4 targeting construct to a mouse embryonic stem (ES) cell, thereby producing an ES cell having silenced C2 region;

(b) introducing the ES cell having the silenced C2 region to a mouse embryo in order to produce a mouse having silenced C2 region by germline transmission;

(c) obtaining a C2 deleted mouse by breeding the mouse of step (b) with another mouse capable of causing deletion of the targeted C2-C4 region by germline transmission;

(d) obtaining ES cells from a progeny mouse of step (c);

(e) introducing a C3-C1 targeting construct to the ES cell of step (d), thereby producing an ES cell having silenced C1 region;

(f) introducing the ES cell of step (e) having the silenced C1 region to a mouse embryo in order to produce a mouse having silenced C1 region by germline transmission; and

(g) obtaining a mouse having deleted lambda locus regions C2-C4-C3-C1 by breeding the mouse of step (f) with another mouse capable of causing deletion of the targeted C3-C1 region in germline transmission, wherein the lambda light chain locus is deleted by using LoxP constructs as the targeting constructs and using a ubiquitous Cre-expresser mouse as the mouse capable of deleting a targeted region.

8. The knock-out mouse according to claim 7 , wherein the mouse heavy chain locus is functionally silenced by targeted integration of a selectable marker gene in the μ membrane exons or targeted deletion of JH gene segment.

9. The knock-out mouse according to claim 8 , wherein the knock-out mouse comprises one or more heavy and/or a light chain genes or loci from a human.

10. The method of producing a knock-out mouse according to claim 5 , wherein the C2-C4 loci and the C3-C1 loci are deleted simultaneously.

11. The method of producing a knock-out mouse according to claim 5 , wherein the C2-C4 loci and the C3-C1 loci are deleted sequentially.

12. The knock-out mouse according to claim 2 , wherein the mouse heavy chain locus is functionally silenced by targeted integration of a selectable marker gene in the μ membrane exons or targeted deletion of JH gene segment.

13. The knock-out mouse according to claim 7 , wherein κ light chain locus is functionally silenced by targeted integration of a selectable marker gene in Cκ or targeted removal of Cκ or Jκ.

14. The knock-out mouse according to claim 13 , wherein the mouse heavy chain locus is functionally silenced by targeted integration of a selectable marker gene in the μ membrane exons or targeted deletion of JH gene segment.

Assignments (1)
CHANGE OF NAME Recorded Sep 15, 2009
From: TRANSLOCUS LIMITED
To: CRESCENDO BIOLOGICS LIMITED
Reel/Frame 023220/0799 →